Martin S. Springer

7.3k citations

65 papers · 4.9k indexed · h-index 38

Molecular Biology top 5%
Immunology top 1%
Virology top 0.5%
Oncology top 5%
Physiology top 5%

Co-authors: Julius Adler Michael F. Goy Salvatore Siciliano Julie A. DeMartino Bruce L. Daugherty Lorraine Malkowitz Thomas E. Rollins Anna Sirotina
Topics: HIV Research and Treatment (19 papers)Chemokine receptors and signaling (12 papers)Receptor Mechanisms and Signaling (12 papers)
Cited by: Virology Immunology Immunology and Allergy
Journals: Nature Science Cell
Partner nations: United States Norway United Kingdom

In The Last Decade

Martin S. Springer

65 papers receiving 4.6k citations

Peers

Countries citing papers authored by Martin S. Springer

Since Specialization

Citations

This map shows the geographic impact of Martin S. Springer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin S. Springer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin S. Springer more than expected).

Fields of papers citing papers by Martin S. Springer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin S. Springer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin S. Springer. The network helps show where Martin S. Springer may publish in the future.

Co-authorship network of co-authors of Martin S. Springer

This figure shows the co-authorship network connecting the top 25 collaborators of Martin S. Springer. A scholar is included among the top collaborators of Martin S. Springer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin S. Springer. Martin S. Springer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CCR5 Blockade Modulates Inflammation and Alloimmunity in Primates 2007 ·The Journal of Immunology ·Carsten Schröder,Richard N. Pierson,Bao-Ngoc Nguyen,D W Kawka,Laurence B. Peterson,Guosheng Wu,Tianshu Zhang,Martin S. Springer,(unknown),Susan A. Iliff,Julia M. Ayala,Min Lu,John S. Mudgett,Kathy Lyons,Sander G. Mills,Geraldine G. Miller,Irwin Singer,Agnes M. Azimzadeh,Julie A. DeMartino	48
2	Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus–cell fusion 2005 ·Nature ·Ronald S. Veazey,Per Johan Klasse,Susan M. Schader,Qinxue Hu,Thomas J. Ketas,Min Lu,Preston A. Marx,Jason Dufour,Richard J. Colonno,Robin J. Shattock,Martin S. Springer,John P. Moore	255
3	Synthesis and evaluation of CCR5 antagonists containing modified 4-piperidinyl-2-phenyl-1-(phenylsulfonylamino)-butane 2005 ·Bioorganic & Medicinal Chemistry Letters ·Shrenik K. Shah,Natalie Chen,(unknown),Sander G. Mills,Lorraine Malkowitz,Martin S. Springer,Sandra L. Gould,Julie A. DeMartino,Anthony Carella,Gwen Carver,Karen Holmes,William A. Schleif,Renee Danzeisen,Daria J. Hazuda,Joseph Kessler,Janet Lineberger,Michael D. Miller,Emilio A. Emini,Malcolm MacCoss	22
4	Syntheses and SAR studies of 4-(heteroarylpiperdin-1-yl-methyl)-pyrrolidin-1-yl-acetic acid antagonists of the human CCR5 chemokine receptor 2004 ·Bioorganic & Medicinal Chemistry Letters ·K. Shankaran,(unknown),Shrenik K. Shah,(unknown),Malcolm MacCoss,Sander G. Mills,Sandra L. Gould,Lorraine Malkowitz,Salvatore Siciliano,Martin S. Springer,Anthony Carella,Gwen Carver,Daria J. Hazuda,Karen Holmes,Joseph Kessler,Janet Lineberger,Michael D. Miller,Emilio A. Emini,William A. Schleif	14
5	Effect of a CCR5 inhibitor on viral loads in macaques dual-infected with R5 and X4 primate immunodeficiency viruses 2004 ·Virology ·Steven M. Wolinsky,Ronald S. Veazey,Kevin Kunstman,Per Johan Klasse,Jason Dufour,Andre J. Marozsan,Martin S. Springer,John P. Moore	47
6	Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 1: Discovery and SAR study of 4-pyrazolylpiperidine side chains 2004 ·Bioorganic & Medicinal Chemistry Letters ·Dong‐Ming Shen,Min Shu,Sander G. Mills,Kevin T. Chapman,Lorraine Malkowitz,Martin S. Springer,Sandra L. Gould,Julie A. DeMartino,Salvatore Siciliano,Gloria Y. Kwei,Anthony Carella,Gwen Carver,Karen Holmes,William A. Schleif,Renee Danzeisen,Daria J. Hazuda,Joseph Kessler,Janet Lineberger,Michael D. Miller,Emilio A. Emini	22
7	Down-regulation of cell surface CXCR6 expression during T cell activation is predominantly mediated by calcineurin 2003 ·Cellular Immunology ·(unknown),(unknown),Martin S. Springer,Sandra L. Gould,Francis J. Dumont	18
8	Radiolabeled Chemokine Binding Assays 2003 ·Humana Press eBooks ·Bruce L. Daugherty,Salvatore Siciliano,Martin S. Springer	9
9	1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 3: polar functionality and its effect on anti-HIV-1 activity 2002 ·Bioorganic & Medicinal Chemistry Letters ·Jeffrey J. Hale,Richard J. Budhu,Sander G. Mills,Malcolm MacCoss,Sandra L. Gould,Julie A. DeMartino,Martin S. Springer,Salvatore Siciliano,Lorraine Malkowitz,William A. Schleif,Daria J. Hazuda,Michael A. Miller,Joseph Kessler,Renee Danzeisen,Karen Holmes,Janet Lineberger,Anthony Carella,Gwen Carver,Emilio A. Emini	10
10	Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 3: A proposed pharmacophore model for 1-[N-(methyl)-N-(phenylsulfonyl)amino]-2-(phenyl)-4-[4-(substituted)piperidin-1-yl]butanes 2001 ·Bioorganic & Medicinal Chemistry Letters ·Paul E. Finke,Laura C. Meurer,Bryan Oates,Shrenik K. Shah,Jennifer L. Loebach,Sander G. Mills,Malcolm MacCoss,(unknown),Lorraine Malkowitz,Martin S. Springer,Sandra L. Gould,Julie A. DeMartino	31
11	Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 4: synthesis and structure–Activity relationships for 1-[N-(Methyl)-N-(phenylsulfonyl)amino]-2-(phenyl)-4-(4-(N-(alkyl)-N-(benzyloxycarbonyl)amino)piperidin-1-yl)butanes 2001 ·Bioorganic & Medicinal Chemistry Letters ·Paul E. Finke,Bryan Oates,Sander G. Mills,Malcolm MacCoss,Lorraine Malkowitz,Martin S. Springer,Sandra L. Gould,Julie A. DeMartino,Anthony Carella,Gwen Carver,Karen Holmes,Renee Danzeisen,Daria J. Hazuda,Joseph Kessler,Janet Lineberger,Michael D. Miller,William A. Schleif,Emilio A. Emini	62
12	Combinatorial synthesis of CCR5 antagonists 2001 ·Bioorganic & Medicinal Chemistry Letters ·Christopher A. Willoughby,Scott C. Berk,(unknown),(unknown),Kevin T. Chapman,Sandra L. Gould,Martin S. Springer,Lorraine Malkowitz,William A. Schleif,Daria J. Hazuda,Michael D. Miller,Joseph Kessler,Renee Danzeisen,Karen Holmes,Janet Lineberger,Anthony Carella,Gwen Carver,Emilio A. Emini	28
13	The chemokine/chemokine-receptor family: potential and progress for therapeutic intervention 2000 ·Current Opinion in Chemical Biology ·Margaret A. Cascieri,Martin S. Springer	76
14	A Critical Site in the Core of the CCR5 Chemokine Receptor Required for Binding and Infectivity of Human Immunodeficiency Virus Type 1 1999 ·Journal of Biological Chemistry ·Salvatore Siciliano,Shawn E. Kuhmann,(unknown),Navid Madani,Martin S. Springer,Janet Lineberger,Renee Danzeisen,Michael D. Miller,Michael P. Kavanaugh,Julie A. DeMartino,David Kabat	67
15	The Amino Terminus of Human CCR5 Is Required for Its Function as a Receptor for Diverse Human and Simian Immunodeficiency Virus Envelope Glycoproteins 1998 ·Virology ·(unknown),Douglas S. Kwon,Morris S. Jones,Craig B. Davis,Shana Marmon,Bruce L. Daugherty,Julie A. DeMartino,Martin S. Springer,Derya Unutmaz,Dan R. Littman	59
16	The β-Chemokine Receptor Genes CCR1 (CMKBR1), CCR2 (CMKBR2), and CCR3 (CMKBR3) Cluster within 285 kb on Human Chromosome 3p21 1997 ·Genomics ·Bruce L. Daugherty,Martin S. Springer	27
17	Cloning, expression, and characterization of the human eosinophil eotaxin receptor. 1996 ·The Journal of Experimental Medicine ·Bruce L. Daugherty,Salvatore Siciliano,Julie A. DeMartino,Lorraine Malkowitz,Anna Sirotina,Martin S. Springer	469
18	Substituted 4,6-diaminoquinolines as inhibitors of C5a receptor binding 1992 ·Journal of Medicinal Chemistry ·Thomas J. Lanza,Philippe L. Durette,Thomas E. Rollins,Salvatore Siciliano,(unknown),Sumire Kobayashi,Charles G. Caldwell,Martin S. Springer,William K. Hagmann	72
19	L-156,602, a C5a antagonist with a novel cyclic hexadepsipeptide structure from Streptomyces sp. MA6348. Fermentation, isolation and structure determination. 1991 ·The Journal of Antibiotics ·Otto D. Hensens,Robert P. Borris,Lawrence R. Koupal,Charles G. Caldwell,Sara Currie,(unknown),Carl F. Homnick,(unknown),(unknown),Cheryl D. Schwartz,(unknown),H. B. Woodruff,Deborah L. Zink,LAURETTA ZITANO,(unknown),Thomas E. Rollins,Martin S. Springer,James P. Springer	42
20	Interaction between the C5a receptor and Gi in both the membrane-bound and detergent-solubilized states. 1990 ·Journal of Biological Chemistry ·Salvatore Siciliano,Thomas E. Rollins,Martin S. Springer	57

About Martin S. Springer

Martin S. Springer is a scholar working on Virology, Immunology and Microbiology, having authored 65 papers that have together received 4.9k indexed citations. Recurring topics across this work include HIV Research and Treatment (19 papers), Chemokine receptors and signaling (12 papers) and Receptor Mechanisms and Signaling (12 papers). The work is most often cited by research in Virology (872 citations), Immunology (1.8k citations) and Immunology and Allergy (333 citations). Martin S. Springer has collaborated with scholars based in United States, Norway and United Kingdom. Frequent co-authors include Julius Adler, Michael F. Goy, Salvatore Siciliano, Julie A. DeMartino, Bruce L. Daugherty, Lorraine Malkowitz, Thomas E. Rollins, Anna Sirotina, Gail Van Riper and Hugh Rosen. Their work appears in journals such as Nature, Science and Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact